Back to News
Market Impact: 0.15
China SXT Pharmaceuticals, Inc. Announces Termination of $12,000,000 Over-Allotment Option
Source: Nasdaq
Company Fundamentals
China SXT Pharmaceuticals said it entered into a termination letter agreement with purchasers on October 21, 2026, ending the Over-Allotment Option in Section 2.4 of its securities purchase agreement dated October 8, 2026. The provided article text contains no further details on the agreement or its financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- SK Hynix shares slide after chipmaker scraps Solidigm IPO plans
- Apple’s iPhone Duo Hits Stores in Face of Short Supply and High Demand
- OpenAI nears up to $30 billion funding round at $1.25 trillion valuation led by UAE investors
- Moderna shares plunge after leak of partial cancer vaccine data
- SpaceX records $561 million investment gain from stake in Elon Musk's Boring Co.
- A lesson from poker tells us not to fold on Meta after its earnings sell-off. Here’s why